Hepatocyte growth factor in Egyptian females with breast benign lumps and cancers

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 893-896

  El Attar, H A ^a   Ragab, M S ^a   Sheta, M I ^a   Ahmed, A S ^b  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Breast lumps; Hepatocyte growth factor; Metastasis

Indexed keywords

EID: 78650695965     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Beviglia L, Kramer RH (1999). HGF induces FAK activation and integrin - mediated adhesion in MLTn3 brast carcinoma cells. Int J Cancer, 83, 640-9.
2. Bonine-Summers AR, Aakre ME, Brown KA, et al (2007). Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells. Cancer Biol Ther, 6, 561-70.
3. Burtis CA, Ashwood ER, Bruns DE (2006). Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4 th Ed. El sevier Saunders Company. St Louis, 870-1, 802, 798, 807-8, 604-7, 609-10.
4. Cao R, Bjorndahl MA, Gallego MI, et al (2006). Hepatocyte growth factor is a novel lymphangiogenic factor with an indirect mechanism of action. Am Soc Hematol, 19, 2538-66.
5. Celis JE, Gromov P, Moreira JMA, et al (2006). Apocrine cysts of the breast. Biomarkers, origin, enlargement and relation with cancer phenotype. Mol Cell Proteomics, 5, 462-83.
6. Cianfrocca M, Goldstein LJ (2004). Prognostic and predictive factors in early-stage breast cancer. Oncologist, 9, 606-16.
7. Eichbaum MH, de Rossi TM, Kaul S, et al (2007).Serum levels of hepatocyte growth factor / scatter factor in patients with liver metastasis from breast cancer. Tumor Biol, 28, 36-44.
8. Favoni RE, De Cupis A (2000). The role of polypeptide growth factors in human carcinomas: New targets for a novel pharmacological approach. Pharmacol Rev, 52, 179-206.
9. Guray M, Sahin AA (2006). Benign Breast Diseases: Classification, Diagnosis and Management. Oncologist, 11, 435-49.
10. Hondermarck H (2003). Breast cancer when proteomics challenge biological complexity. Mol Cell Proteomics, 2, 281-91.
11. Jin L, Fuchs A, Schnett SJ, et al (1997). Expression of scatter factor and c - met receptor in benign and malignant breast tissue. Cancer, 79, 749-60.
12. Liu Y (2006). Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. Kidney Int, 69, 213-7.
13. Nagy J, Curry GW, Hillan KJ, et al (1996). Hepatocyte growth factor/Scatter factor expression and c - met in primary breast cancer. Surg Oncol, 5, 15-21.
14. Ohnishi T, Kakimoto K, Bandow K, et al (2006). Mature Hepatocyte growth factor/Scatter factor on the surface of human granulocytes is released by a mechanism involving activated Factor Xa. J Immunol, 176, 6945-53.
15. Parr C, Watkins G, Mansel RE, et al (2004). The hepatocyte growth factor regulatory factor, in human breast cancer. Clin Cancer Res, 10, 202-11.
16. Peruzzi B, Bottaro DP (2006). Targeting the c-Met signaling pathway in cancer. Clin Cancer Res, 12, 3657-60.
17. Pollard JW (2001). Tumor - stromal interactions: Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis. Breast Cancer Res, 3, 230-7.
18. Rahimi-Hung W, Tremblay E, Saulnier R, et al (1998). C-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells. J Biol Chem, 273, 33714-21.
19. Sheen-Chen SM, Liu YW, Eng HL, et al (2005). Serum levels of Hepatocyte Growth Factor in patients with breast cancer. Cancer Epidemiol Biomarkers Prev. 14, 715-7.
20. Sung HJ, Kim SY, Kim CK, et al (2003). Clinical usefulness of circulating hepatocyte growth factor (HGF) in breast cancer. Korean J Lab Med, 23, 309-14.
21. Taniguchi T, Toi M, Inada K, et al (1995). Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res. 1, 1031-4.
22. Tuck AB, Park M, Sterns EE, et al (1996). Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol. 148, 225-32.
23. Wei-Kai H, Yu-xiu, Ting Y, et al (2007). Adipocytokines and breast cancer risk. Chim Med J, 120, 1592-6.
24. Yamashita JI, Ogawa M, Yamashita SI, et al (1994). Immunoreactive Hepatocyte Growth Factor is a strong and independent predictor of recurrence and Survival in Human Breast Cancer. Cancer Res. 54, 1630.